Todd C. Brady
2019
In 2019, Todd C. Brady earned a total compensation of $4.1M as President and Chief Executive Officer at Aldeyra Therapeutics, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $235,350 |
|---|---|
| Option Awards | $1,359,210 |
| Salary | $523,000 |
| Stock Awards | $2,012,500 |
| Other | $11,201 |
| Total | $4,141,261 |
Brady received $2M in stock awards, accounting for 49% of the total pay in 2019.
Brady also received $235.4K in non-equity incentive plan, $1.4M in option awards, $523K in salary and $11.2K in other compensation.
Rankings
In 2019, Todd C. Brady's compensation ranked 2,861st out of 13,971 executives tracked by ExecPay. In other words, Brady earned more than 79.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,861 out of 13,971 | 80th |
Division Manufacturing | 1,036 out of 5,701 | 82nd |
Major group Chemicals And Allied Products | 344 out of 2,200 | 84th |
Industry group Drugs | 281 out of 1,886 | 85th |
Industry Pharmaceutical Preparations | 207 out of 1,398 | 85th |
Source: SEC filing on April 27, 2020.
Brady's colleagues
We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2019.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019